Bellevue Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,617,446
| Closed | -$2.5M | – | 237 |
|
|
2020
Q4 | $2.5M | Buy |
3,617,446
+2,817,446
| +352% | +$1.94M | 0.03% | 141 |
|
|
2020
Q3 | $1.8M | Hold |
800,000
| – | – | 0.02% | 146 |
|
|
2020
Q2 | $2.86M | Sell |
800,000
-16,600
| -2% | -$59.4K | 0.04% | 131 |
|
|
2020
Q1 | $3.1M | Hold |
816,600
| – | – | 0.06% | 119 |
|
|
2019
Q4 | $2.46M | Buy |
+816,600
| New | +$2.46M | 0.04% | 126 |
|